NCT01711424View on ClinicalTrials.gov

An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

CompletedOBSERVATIONAL
Enrollment

1,209

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Dry Eye Syndromes
Interventions
DRUG

OPTIVE PLUS®

Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice.

Trial Locations (1)

Unknown

Stuttgart

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01711424 - An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease | Biotech Hunter | Biotech Hunter